More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk

TUESDAY, Feb. 22, 2022 -- Among patients with a history of ischemic stroke, more intensive low-density lipoprotein cholesterol (LDL-C)-lowering statin-based therapies are associated with a decreased risk for recurrent stroke but an increased risk...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news